Nieuws

Moderna’s respiratory syncytial virus (RSV) vaccine mRESVIA has been approved by the US Food and Drug Administration (FDA) ...
De Amerikaanse Food and Drug Administration (FDA) heeft maandag toestemming gegeven voor Merck’s preventieve antistofinjectie ...
The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...
De Amerikaanse Food and Drug Administration heeft maandag Merck's preventieve antilichaam goedgekeurd om zuigelingen tot één ...
Moderna's shares fell 2.3% on Friday on concerns about whether a new CDC advisory panel would back the use of the company's ...
In other developments, the ECDC today reported a slow rise in COVID activity in the Europe, which may partly reflect waning ...
Moderna's shares fell 2.5% before the bell on Friday, on concerns whether a new CDC advisory panel would back the use of the ...
The agency’s decision to clear Moderna’s shot for use in certain younger adults is a much-needed win for a company that’s ...
A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization ...
It starts with a sniffle. A mild cough. You tell yourself it’s just a cold—babies get those, right? But make no mistake. RSV ...
The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to ...
RAHWAY, N.J. - Merck & Co . Inc. (NYSE: MRK) heeft vandaag bekendgemaakt dat de U.S. Food and Drug Administration (FDA) haar monoklonale antilichaam, ENFLONSIAâ„¢ (clesrovimab-cfor), heeft goedgekeurd v ...